286 related articles for article (PubMed ID: 24055694)
1. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
[TBL] [Abstract][Full Text] [Related]
2. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
[TBL] [Abstract][Full Text] [Related]
4. Association of high post-transplant soluble CD30 serum levels with chronic allograft nephropathy.
Grenzi PC; Campos ÉF; Tedesco-Silva H; Felipe CR; Franco MF; Soares MF; Medina-Pestana JO; Gerbase-Delima M
Transpl Immunol; 2013 Dec; 29(1-4):34-8. PubMed ID: 23928467
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vitko S; Skibová J; Striz I
Transpl Immunol; 2005 Jun; 14(2):117-21. PubMed ID: 15935302
[TBL] [Abstract][Full Text] [Related]
6. Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival.
Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Solgi G
Transplant Proc; 2015 May; 47(4):1110-3. PubMed ID: 26036531
[TBL] [Abstract][Full Text] [Related]
7. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
9. Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant.
Domingues EM; Matuck T; Graciano ML; Souza E; Rioja S; Falci MC; Monteiro de Carvalho DB; Porto LC
Clin Transplant; 2010; 24(6):821-9. PubMed ID: 20047612
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients.
Billing H; Sander A; Süsal C; Ovens J; Feneberg R; Höcker B; Vondrak K; Grenda R; Friman S; Milford DV; Lucan M; Opelz G; Tönshoff B
Transpl Int; 2013 Mar; 26(3):331-8. PubMed ID: 23279372
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft.
Pavlova Y; Viklicky O; Slatinska J; Bürgelova M; Süsal C; Skibova J; Honsová E; Striz I; Kolesar L; Slavcev A
Transpl Immunol; 2011 Jul; 25(1):72-6. PubMed ID: 21376809
[TBL] [Abstract][Full Text] [Related]
12. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
[TBL] [Abstract][Full Text] [Related]
13. Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1year post-transplantation.
Wang D; Wu G; Chen J; Yu Z; Wu W; Yang S; Tan J
Transpl Immunol; 2012 Jun; 26(4):235-9. PubMed ID: 22446727
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation.
Hamer R; Roche L; Smillie D; Harmer A; Mitchell D; Molostvov G; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Briggs D; Lowe D; Zehnder D; Higgins R
Transpl Immunol; 2010 Aug; 23(4):161-5. PubMed ID: 20600903
[TBL] [Abstract][Full Text] [Related]
15. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
Wang D; Wu W; Yang S; Wang Q; Tan J
Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
[TBL] [Abstract][Full Text] [Related]
16. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against MICA antigens and kidney-transplant rejection.
Zou Y; Stastny P; Süsal C; Döhler B; Opelz G
N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of pre- and post-transplant HLA antibodies, donor-specific, and nondonor-specific HLA antibodies detected by ELISA in renal transplantation.
Lee PC; Chen YL; Wang WM; Tu WC; Chen HY
Clin Transpl; 2013; ():385-91. PubMed ID: 25095533
[TBL] [Abstract][Full Text] [Related]
20. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
Wang D; Wu GJ; Wu WZ; Yang SL; Chen JH; Wang H; Lin WH; Wang QH; Zeng ZX; Tan JM
Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
